Shionogi Covid pill Xocova fails to win Japan panel backing

Jul 21, 2022 | News On Japan

Jul 21, 2022 (theedgemarkets.com) - Shionogi's experimental Covid-19 treatment Xocova failed to win the backing of health experts in Japan who said there wasn’t enough data to show the medicine’s efficacy.

The panel members didn’t recommend that Japan’s health ministry authorise emergency use of the therapy as there was a need to continue discussion on it, Hiroshi Kiyota, chairman of the expert committee said in a briefing Wednesday. The health ministry relies on the panel’s decision to give the approval.

Shionogi plummeted as much as 10% in Tokyo trading, the biggest intraday drop since June 23, while shares of Shionogi’s South Korean partner, Il Dong Pharmaceutical Co, fell as much as 30% in Seoul.

Japan so far has two pills to fight coronavirus and Shionogi’s therapy was seeking to be the third option. Approval for Shionogi’s medicine was keenly watched as it is easier to take than the two currently available drugs from US drugmakers. A course of Shionogi treatment consists of seven pills over five days — significantly fewer than Pfizer Inc’s Paxlovid and Merck & Co’s Lagevrio, which require between 30 pills and 40 pills over the same time period.

Source: ANNnewsCH

Typhoons No. 28 and 29 Bring High Waves to Japan's Pacific Coast

Two typhoons moving across the Pacific southeast of Japan are expected to remain well away from the Japanese mainland, but powerful swells could bring rough seas to a wide stretch of the country's Pacific coastline throughout the three-day holiday weekend, according to forecasts updated at 3 a.m. on October 10.

Cyberattacks Spread Across Japan

A series of cyberattacks has disrupted business operations and exposed millions of customer records across Japan, with a ransomware attack on a cloud service provider affecting 495 companies and local governments nationwide, while convenience store operator Lawson has disclosed a separate breach involving more than 2.15 million personal information records.

Japan's First 360-Degree Projection Mapping Opens in Osaka

Japan's first 360-degree projection mapping show will open at the Osaka City Museum of Fine Arts on October 10, transforming the historic building into an immersive world of light, music, and seasonal imagery, with organizers hoping the attraction will also help stimulate the city's nighttime economy.

Tokyo University Professor Wins Nobel Prize in Chemistry

Tokyo University of Science professor emeritus Kenzo Soai has been awarded this year's Nobel Prize in Chemistry together with French chemist Henri B. Kagan for discoveries that transformed scientists' understanding of how chemical reactions can favor one of two mirror-image forms of a molecule.

US Military Halts All Okinawa Operations for 48 Hours

The US military suspended activities by all forces stationed in Okinawa for 48 hours from noon on October 7, an unusual measure following the arrest of a US Marine in connection with a robbery and murder case that has renewed scrutiny of crimes involving American service members.

MEDIA CHANNELS

MORE Sci-Tech NEWS

Humanoid Robots Set to Enter Japanese Convenience Stores

Humanoid robots capable of stocking shelves, managing inventory, packaging products, and serving customers in more than 20 languages were showcased at an international retail industry event in Tokyo on October 8, highlighting the growing potential of artificial intelligence to transform store operations as Japan struggles with chronic labor shortages.

Tokyo University Professor Wins Nobel Prize in Chemistry

Qilin Hacker Detained in Japan

A core member of the international ransomware group Qilin was detained in Japan and handed over to German authorities, according to people familiar with the case, as Japanese companies and institutions face a growing wave of cyberattacks that has exposed nearly 15 million pieces of personal information this month alone.

Japan Startup Begins Building Rare Earth Production Facility

Miresso, a Japanese startup backed by trading house Mitsui & Co., has announced the start of construction of a facility to produce beryllium, a rare metal essential for nuclear fusion power generation, with plans to manufacture 100 tons annually, equivalent to about one-third of current global production.

World’s First iPS Cell Heart Surgery Performed in Osaka

A woman in her 50s with severe heart failure underwent what was described as the world's first surgery using commercially available iPS cell-derived heart muscle sheets at an Osaka hospital on September 29, marking the first practical use of the regenerative treatment.